Maximising Efficiency in Clinical Outsourcing

By Pharma Iq, PRNE
Monday, February 21, 2011

MUNICH, Germany, February 22, 2011 - Driving clinical development and speeding time to market through
effective relationship management will be two of the key themes discussed at
Pharma IQ's 2nd Annual Global Clinical Outsourcing Forum this May.

A recent survey carried out by Pharma IQ revealed some telling stats
about the current market activities; 67% of pharmaceutical and biotechnology
companies outsource more than HALF of all clinical trials.

However, the risks involved cannot be ignored; with inefficiencies
leading to 70% of all trials failing to complete on time, costing
manufacturers $1.1m in daily prescription revenues.

Last year, a report by the Association of Clinical Research Organisations
(ARCO) into overseas clinical trials found that CROs have taken steps to
ensure that both quality and ethical standards are the same in all countries
in which they operate, and now a further study is in the pipeline.

FDA Officials have backed up this view by indicating that they would be
"tightening regulations for pharmaceutical companies that outsource
manufacturing to emerging markets to enhance the safety of products."

This is also highlighted by survey results revealing the perceived
biggest obstacles to outsourcing:

    1) Establishing CRO accountability
    2) Running trials in emerging markets
    3) Entering into risk sharing partnerships

For access to these reports and more (completely free of charge) visit
the Global Clinical Outsourcing Forum download centre at bit.ly/fpKYU5

All of these issues will be discussed in depth by the heads of clinical
operations and outsourcing from companies such as Pfizer, Genzyme and Merck
Serono at Pharma IQ's 2nd Annual Global Clinical Outsourcing Forum, which
will be held from 16th - 18th of May 2011. It will be the largest gathering
in Europe of decision makers in the realm of clinical outsourcing.

About IQPC

IQPC provides business executives around the world with tailored
practical conferences, large scale events, topical seminars and in-house
training programs, keeping them up-to-date with industry trends,
technological developments and the regulatory landscape. IQPC leverages a
global research base of best practices to produce an unrivalled portfolio of
conferences. www.iqpc.com.

For more information about the speaker line up and to access exclusive
and complimentary reports, please visit
www.globalclinicaloutsourcing.com or phone +44(0)207-368-9300.

Media contact: Jack Scott, +44(0)20-7368-9502, jack.scott@iqpc.co.uk or
visit www.globalclinicaloutsourcing.com

For more information about the speaker line up and to access exclusive
and complimentary reports, please visit www.globalclinicaloutsourcing.com or phone +44(0)207-368-9300. Media contact: Jack Scott, +44(0)20-7368-9502, jack.scott at iqpc.co.uk or
visit www.globalclinicaloutsourcing.com

Surveys / Polls / Research News

February 22 News

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :